CKS1B and lung carcinoma: Kaplan-Meier estimates of event-free survival (left panel), metastasis-free survival (middle panel), and overall survival (right panel) found that recurrent primary human (RPH) lung cancer patients with CKS1B overexpression showed decreased survival compared to that of incipient primary human (IPH) lung cancer patients (Figure 1) (25).